St. Luke's Cancer Institute — Boise, Idaho

St. Luke's Cancer Institute is a clinical research site located in Boise, Idaho, United States 83712.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

St. Luke's Cancer Institute has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Colorectal Adenocarcinoma, Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8.

Sponsors: M.D. Anderson Cancer Center, Kite, A Gilead Company, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Luke's Cancer Institute?

St. Luke's Cancer Institute has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Luke's Cancer Institute conducted?

St. Luke's Cancer Institute has 5 clinical trials on record, with 3 currently active. Their work covers Colorectal Adenocarcinoma, Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8.

Is St. Luke's Cancer Institute accredited by Crixeo Health?

St. Luke's Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St. Luke's Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.